Works matching IS 14363291 AND DT 2018 AND VI 21 AND IP 5
Results: 17
Quantitative assessment of fluorescence intensity of ICG in sentinel nodes in early gastric cancer.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 776, doi. 10.1007/s10120-018-0816-z
- By:
- Publication type:
- Article
A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 811, doi. 10.1007/s10120-018-0815-0
- By:
- Publication type:
- Article
Clinical outcomes of intraoperative manual dilatation of pylorus in pylorus-preserving gastrectomy: a retrospective analysis.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 864, doi. 10.1007/s10120-018-0814-1
- By:
- Publication type:
- Article
Molecular profiling and comprehensive genome-wide analysis of somatic copy number alterations in gastric intramucosal neoplasias based on microsatellite status.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 765, doi. 10.1007/s10120-018-0810-5
- By:
- Publication type:
- Article
A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 782, doi. 10.1007/s10120-018-0809-y
- By:
- Publication type:
- Article
Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 729, doi. 10.1007/s10120-018-0807-0
- By:
- Publication type:
- Article
Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 819, doi. 10.1007/s10120-018-0806-1
- By:
- Publication type:
- Article
Two-point measurement of amylase in drainage fluid predicts severe postoperative pancreatic fistula after gastric cancer surgery.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 871, doi. 10.1007/s10120-018-0805-2
- By:
- Publication type:
- Article
Total vs proximal gastrectomy for adenocarcinoma of the upper third of the stomach: a propensity-score-matched analysis of a multicenter western experience (On behalf of the Italian Research Group for Gastric Cancer-GIRCG).
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 845, doi. 10.1007/s10120-018-0804-3
- By:
- Publication type:
- Article
Novel epigenetic markers for gastric cancer risk stratification in individuals after Helicobacter pylori eradication.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 745, doi. 10.1007/s10120-018-0803-4
- By:
- Publication type:
- Article
Predictors of heterogeneity in the first-line treatment of patients with advanced/metastatic gastric cancer in the U.S.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 738, doi. 10.1007/s10120-018-0802-5
- By:
- Publication type:
- Article
HOTAIR induces the ubiquitination of Runx3 by interacting with Mex3b and enhances the invasion of gastric cancer cells.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 756, doi. 10.1007/s10120-018-0801-6
- By:
- Publication type:
- Article
Which method is more suitable for advanced gastric cancer with enlarged lymph nodes, laparoscopic radical gastrectomy or open gastrectomy?
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 853, doi. 10.1007/s10120-018-0800-7
- By:
- Publication type:
- Article
Preliminary opinion on assessment categories of stomach ultrasound report and data system (Su-RADS).
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 879, doi. 10.1007/s10120-018-0798-x
- By:
- Publication type:
- Article
Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practices.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 831, doi. 10.1007/s10120-018-0796-z
- By:
- Publication type:
- Article
Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 802, doi. 10.1007/s10120-018-0794-1
- By:
- Publication type:
- Article
First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 792, doi. 10.1007/s10120-018-0797-y
- By:
- Publication type:
- Article